Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T

Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T

Abstract In recent decades, immune checkpoint blockade and chimeric antigen receptor T cell (CAR-T) therapy are two milestone achievements in clinical immunotherapy. However, both show limited efficacies in most solid neoplasms, which necessitates the exploration of new immunotherapeutic modalities....

Full description

Bibliographic Details
Main Authors: Qiaofei Liu, Jiayi Li, Huaijin Zheng, Sen Yang, Yuze Hua, Nan Huang, Jorg Kleeff, Quan Liao, Wenming Wu
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Molecular Cancer
Subjects:
Adoptive cell therapy
Immune checkpoint
Chimeric antigen receptor
TCR
Natural killer cell
Macrophage
Online Access:https://doi.org/10.1186/s12943-023-01735-9

Internet

https://doi.org/10.1186/s12943-023-01735-9

Similar Items